8 results
An algorithm created for classifying MDS according to the new 2017 WHO Classification.

- Kyle Bradley, MD
An algorithm created ... the new 2017 WHO Classification ... Diagnosis #Hemepath #HOnc ... Myelodysplastic #Syndrome #Classification ... #Algorithm #WHO2017
An algorithm for classifying AML according to the new 2017 WHO Classification. Useful for determining which
An algorithm for ... the new 2017 WHO Classification ... Diagnosis #Hemepath #HOnc ... #AML #Classification ... Myeloid #Leukemia #Algorithm
Signaling Mechanism of PD-1 and PD-L1 and Inhibition of PD-1 Signaling in Microsatellite-Instability–High Cancers. MHC1 denotes
histocompatibility complex 1 #Pathophysiology ... #Honc #Pharm #PD1 ... MicrosatelliteInstability #NEJM
Approach to Selecting Respiratory Support:
-The role of noninvasive respiratory support is generally to reduce the patient's
HFNC may be made ... CriticalCare #BiPAP #BiLevel ... #HFNC #HighFlow ... RespiratorySupport #Selection #Algorithm
â–ş
Hemorrhagic Shock Coagulopathy #Pathophysiology #Honc #Coagulopathy #HemorrhagicShock #NEJM
Coagulopathy #Pathophysiology ... #Honc #Coagulopathy ... HemorrhagicShock #NEJM
Hemolysis in Hereditary Spherocytosis. Panel A shows the structure of a normal red cell and a
#Pathophysiology ... #Honc #IM #Spherocytosis ... HereditarySpherocytosis #NEJM
Diagnostic Algorithm for Non–Small-Cell Lung Cancer (NSCLC). The upper portion of the algorithm shows the morphologic
Diagnostic Algorithm ... portion of the algorithm ... the morphologic classification ... #Diagnosis #Honc ... #PDL1 #NEJM
Immunosuppressive Strategies for the Prevention or Treatment of Acute GVHD. Panel A shows several classic immunosuppressive
#Pathophysiology ... #IM #Honc #Pharm ... Immunosuppression #NEJM